Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone pretreatment for prevention of atrial fibrillation after CABG
IRCT20251228068478N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Guilan University of Medical Sciences. Primary endpoint: Incidence of postoperative atrial fibrillation. Started Dec 2025; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT20251228068478N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251228068478N1.